Lv, X., Cao, X., Xia, W., Liu, K., Qiang, M., Guo, L., . . . Liu, G. (2021). Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: An open-label, non-inferiority, randomised, controlled, phase 3 trial. Lancet Oncology, 22(5), 716-727.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Lv, Xing, et al. "Induction Chemotherapy with Lobaplatin and Fluorouracil Versus Cisplatin and Fluorouracil Followed by Chemoradiotherapy in Patients with Stage III-IVB Nasopharyngeal Carcinoma: An Open-label, Non-inferiority, Randomised, Controlled, Phase 3 Trial."
Lancet Oncology 22, no. 5 (2021): 716-727.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Lv, Xing, et al. "Induction Chemotherapy with Lobaplatin and Fluorouracil Versus Cisplatin and Fluorouracil Followed by Chemoradiotherapy in Patients with Stage III-IVB Nasopharyngeal Carcinoma: An Open-label, Non-inferiority, Randomised, Controlled, Phase 3 Trial."
Lancet Oncology, vol. 22, no. 5, 2021, pp. 716-727.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.